skip to main content
Guest
e-Shelf
My Account
Sign out
Sign in
This feature requires javascript
Tags
e-Journals
e-Books
Databases
USP Libraries
Help
Help
Language:
English
Spanish
Portuguese (Brazil)
This feature required javascript
This feature requires javascript
Primo Search
General Search
General Search
Physical Collection
Physical Collections
USP Intelectual Production
USP Production
Search For:
Clear Search Box
Search in:
General Search
Or select another collection:
Search in:
General Search
Advanced Search
Browse Search
This feature requires javascript
This feature requires javascript
Waiting for the Revolution
MARSHALL, ELIOT
Science (American Association for the Advancement of Science), 2011-02, Vol.331 (6017), p.526-529
[Peer Reviewed Journal]
American Association for the Advancement of Science
Full text available
Citations
Cited by
View Online
Details
Reviews & Tags
More
Times Cited
This feature requires javascript
Actions
Add to e-Shelf
Remove from e-Shelf
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Waiting for the Revolution
Author:
MARSHALL, ELIOT
Subjects:
Cancer
;
DNA
;
Genetic mutation
;
Genomics
;
Human genetics
;
Human genome
;
HUMAN GENOME 10TH ANNIVERSARY
;
Lynch syndrome II
;
Medical genetics
;
Primary health care
;
Tumors
Is Part Of:
Science (American Association for the Advancement of Science), 2011-02, Vol.331 (6017), p.526-529
Description:
Having the complete human DNA sequence hasn't yet produced big advances in primary medicine, prompting some to ask what's delaying the genomic revolution in health care. Medical schools and research centers are investing tens of millions of dollars each to join the genomic medicine bandwagon. Yet some say this is a huge leap into uncharted clinical territory. Most doctors have not embraced the genomic revolution, according to leaders of medical professional groups, because they have trouble seeing how it will benefit their patients. DNA testing is growing rapidly in oncology to guide the treatment of some cancers and in screening couples before conception and newborns to find dangerous mutations, and many labs are developing therapies to narrowly target tumor DNA. But aside from these situations, applications are scant; most public health reviews of DNA-based approaches have not found a health benefit. As doctors and scientists look back over the decade since the human genome was published, some are asking tough questions. Is the translation of DNA research into medical practice taking longer than expected? Has the genomic medicine revolution faltered? This News story and another on gene patents (p. 530 ) launch a series of features this month commemorating the 10th anniversary of Science 's and Nature 's publications of the human genome, which are gathered here .
Publisher:
American Association for the Advancement of Science
Language:
English
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(USP_PRODUCAO),scope:(USP_EBOOKS),scope:("PRIMO"),scope:(USP),scope:(USP_EREVISTAS),scope:(USP_FISICO),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript